DexCom
Trade DexCom 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About DXCM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.
DXCM Key Statistics
DXCM News
Dexcom (DXCM) has disclosed a new risk, in the Share Price & Shareholder Rights category. Elevate Your Investing Strategy: Take advantage of TipRanks Premium...
Close Key Takeaways The world's largest online retailer got a boost from its booming cloud computing business on Friday, Oct. 31, 2025, while a soft sales outl...
The diabetes equipment provider had a strong quarter, but next year is looking weaker than expected. Shares of diabetes management equipment provider DexCom (D...
Analyst ratings
84%
of 32 ratingsMore DXCM News
In early trading on Friday, shares of Amazon.com topped the list of the day's best performing components of the Nasdaq 100 index, trading up 11.8%. Year to date...
In early trading on Friday, shares of First Solar topped the list of the day's best performing components of the S&P 500 index, trading up 12.3%. Year to date,...
TD Cowen lowered the firm’s price target on DexCom (DXCM) to $84 from $100 and keeps a Buy rating on the shares. The firmsaid they possted a solid Q3 and they s...
Dexcom's (DXCM) solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook. But analysts remained upbeat even as Dexcom stock tum...
Patrick Wood, an analyst from Morgan Stanley, maintained the Hold rating on Dexcom. The associated price target is $89.00. Elevate Your Investing Strategy: Take...
Analyst Josh Jennings of TD Cowen maintained a Buy rating on Dexcom, reducing the price target to $84.00. Elevate Your Investing Strategy: Take advantage of Tip...
Earnings Call Insights DexCom projects 15% revenue growth for 2025 while advancing type 2 diabetes market coverage Oct. 30, 2025 8:27 PM ET DexCom, Inc. (DXCM)...
